Join the Hypertension group to help and get support from people like you.
Hypertension News (Page 10)
Hypertension Prevalence 22.7 Percent Among Young Adults
MONDAY, Sept. 9, 2024 – The prevalence of hypertension is 22.7 percent among young adults aged 18 to 39 years and 5.4 percent among youth aged 8 to 19 years, according to two studies presented at...
6.7 Percent of U.S. Adults Cannot Use Automatic BP Devices Due to Arm Size
FRIDAY, Sept. 6, 2024 – An estimated 6.7 percent of U.S. adults cannot use popular automatic blood pressure devices due to arm circumference, according to a research letter published online Sept. 5...
Cuffs on At-Home Blood Pressure Monitors Don't Fit Some Patients
FRIDAY, Sept. 6, 2024 – People are encouraged to monitor their blood pressure at home, but many folks will find that household blood-pressure cuffs are literally a bad fit, a new study warns. For as...
Almost 1 in 4 U.S. Adults Under 40 Have High Blood Pressure
FRIDAY, Sept. 6, 2024 – An epidemic of high blood pressure is occurring in young adults and children in the United States, a pair of new studies show. Nearly a quarter of people ages 18 to 39 have...
Could Your Cellphone Be Harming Your Heart?
WEDNESDAY, Sept. 4, 2024 – Your cellphone might be harming your heart, a new study warns. People who regularly use a cellphone have a higher risk of heart disease, researchers found in a large-scale...
3-in-1 Blood Pressure Pill Could Be Treatment Advance
WEDNESDAY, Sept. 4, 2024 – An experimental three-in-one blood pressure pill works better than layering on meds one at a time, a new clinical trial shows. After a month on the combo pill, 81% of...
Factory Noise Tied to Higher Blood Pressure in Workers
FRIDAY, Aug. 30, 2024 – There is an independent association between noise exposure duration and elevated blood pressure in factory workers, according to a study presented at ACC Asia 2024, the joint ...
High, Long-Term Consumption of Caffeine May Pose Cardiovascular Risk
FRIDAY, Aug. 30, 2024 – Long-term, daily intake of high levels of caffeine impacts recovery of heart rate and blood pressure following physical exertion, according to a study presented at ACC Asia...
Prevalence of HTN Increases With Neighborhood Disadvantage
MONDAY, Aug. 26, 2024 – The prevalence of hypertension increases with neighborhood disadvantage, according to a study published online Aug. 23 in JAMA Network Open. Madeleine M. Blazel, from the...
FDA Approves Tryvio (aprocitentan) for the Combination Treatment of Resistant Hypertension
RADNOR, Pa., March 20, 2024 /PRNewswire/ – Idorsia Pharmaceuticals U.S. Inc. announced today that the US Food and Drug Administration (FDA) has approved Tryvio™ (aprocitentan) for the treatment of h...
FDA Approves Norliqva (amlodipine) Oral Solution for Hypertension and Coronary Artery Disease
February 28, 2022 - The U.S. Food and Drug Administration has approved Norliqva (amlodipine) oral solution for the treatment of: Hypertension in adults and children 6 years and older, to lower blood...
FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older
WOBURN, Mass. (July 10, 2019) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, ann...
FDA Medwatch Alert: Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg Due to The Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity, Found in an Active Pharmaceutical Ingredient (API)
As a precautionary measure, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired lots of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg to the hospital, retail and consumer level....
FDA Approves Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain
TEL AVIV, Israel, May 31, 2018 (GLOBE NEWSWIRE) – Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration...
FDA Medwatch Alert: Labetalol Hydrochloride Injection by Hospira: Recall - Potential For Cracked Glass At Rim Surface Of Vials
ISSUE: Hospira is voluntarily recalling 3 lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial (NDC 0409-2267-20), and one lot of Labetalol Hydrochloride Injection, USP, Novaplus (NDC...
Further information
Related condition support groups
Cardiovascular Conditions and Disorders
Related drug support groups
lisinopril, metoprolol, amlodipine, propranolol, losartan, hydrochlorothiazide, atenolol, spironolactone, clonidine, view more... carvedilol, Metoprolol Succinate ER, diltiazem, Bystolic, Lasix, Metoprolol Tartrate, furosemide, bisoprolol, valsartan, Norvasc, ramipril, guanfacine, minoxidil, prazosin, verapamil, nitroglycerin, Benicar, Diovan, nifedipine, Coreg